The Bell2Bell (B2B) Podcast

Bell2Bell’s latest podcast features Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Throughout the interview, Stang discussed the Delic ecosystem of businesses and examined how psychedelic research is driving a paradigm shift in the treatment of mental health.

“Delic is the world’s first psychedelic wellness corporation. We have three different businesses, but they all create this amazing ecosystem,” Stang said. “We have the largest chain of psychedelic wellness clinics in America, with 12 clinics operational today under the Ketamine Wellness Centers and Ketamine Infusion Centers brands. We have Delic Labs, a Health Canada-licensed lab in Vancouver with licenses to do scientific research around cannabis, hemp and psychedelics, doing work for major companies across the space. And we have a media and events platform. I just came back from the largest psychedelic event in America; it’s called Meet Delic. We had our first year; we had over 2,500 people in attendance and some incredible names speaking. Then, we have a media platform called Reality Sandwich, which gets a couple hundred thousand people a month looking for information about psychedelics.”

Bell2Bell’s latest podcast features Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Throughout the interview, Stang discussed the Delic ecosystem of businesses and examined how psychedelic research is driving a paradigm shift in the treatment of mental health.

“Delic is the world’s first psychedelic wellness corporation. We have three different businesses, but they all create this amazing ecosystem,” Stang said. “We have the largest chain of psychedelic wellness clinics in America, with 12 clinics operational today under the Ketamine Wellness Centers and Ketamine Infusion Centers brands. We have Delic Labs, a Health Canada-licensed lab in Vancouver with licenses to do scientific research around cannabis, hemp and psychedelics, doing work for major companies across the space. And we have a media and events platform. I just came back from the largest psychedelic event in America; it’s called Meet Delic. We had our first year; we had over 2,500 people in attendance and some incredible names speaking. Then, we have a media platform called Reality Sandwich, which gets a couple hundred thousand people a month looking for information about psychedelics.”

Bell2Bell’s latest podcast features Imperium Motor Company CEO Rick Curtis and Imperium Motor Company Canada President Christian Dubois. Imperium Motor Company, a subsidiary of DSG Global Inc. (OTCQB: DSGT), seeks to transform the way the world drives by making greener transportation available to everyone.

Throughout the interview, Curtis and Dubois discussed the history, current operations and future outlook of Imperium Motor Company.

“The Imperium company idea started out when we had a client who wanted to equip his fleet of electric vehicles with a device for tracking and set up a geo-fence that could limit his drivers’ area of operation,” Curtis explained. “I knew and worked with [DSG Global CEO] Bob Silzer on a few other projects over the years, and I knew he had the solution. We always talked about doing something together, and then, the time was right. Imperium uses a traditional sales channel, with a distributor-dealer model. In the near future, we will assemble some of our products in North America. Then, we would be [executing] a manufacturer-distributor-dealer model. We also will be distributing the INDI One vehicle, as well as the CMW Sagitta. They are both manufactured in North America.”

Bell2Bell’s latest podcast features Imperium Motor Company CEO Rick Curtis and Imperium Motor Company Canada President Christian Dubois. Imperium Motor Company, a subsidiary of DSG Global Inc. (OTCQB: DSGT), seeks to transform the way the world drives by making greener transportation available to everyone.

Throughout the interview, Curtis and Dubois discussed the history, current operations and future outlook of Imperium Motor Company.

“The Imperium company idea started out when we had a client who wanted to equip his fleet of electric vehicles with a device for tracking and set up a geo-fence that could limit his drivers’ area of operation,” Curtis explained. “I knew and worked with [DSG Global CEO] Bob Silzer on a few other projects over the years, and I knew he had the solution. We always talked about doing something together, and then, the time was right. Imperium uses a traditional sales channel, with a distributor-dealer model. In the near future, we will assemble some of our products in North America. Then, we would be [executing] a manufacturer-distributor-dealer model. We also will be distributing the INDI One vehicle, as well as the CMW Sagitta. They are both manufactured in North America.”

Bell2Bell’s latest podcast features Chris Carl, CEO of DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF), an artificial intelligence technology and services company.

Throughout the interview, Carl discussed DigiMax’s history and business model focused on applying AI across various industries and verticals.

“The company was founded four years ago, and we were interested at the time in all things blockchain- and crypto-related,” Carl said. “Four years ago, bitcoin, obviously, was already becoming very popular. The rest of the technology that surrounded the crypto market people weren’t quite sure about, but it definitely looked like it was here to stay, not unlike the internet and the various dotcom strategies going on in the late ‘90s. Everybody had a good sense of where we were headed at a global level but not really individually what applications were going to work best.”

Bell2Bell’s latest podcast features Chris Carl, CEO of DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF), an artificial intelligence technology and services company.

Throughout the interview, Carl discussed DigiMax’s history and business model focused on applying AI across various industries and verticals.

“The company was founded four years ago, and we were interested at the time in all things blockchain- and crypto-related,” Carl said. “Four years ago, bitcoin, obviously, was already becoming very popular. The rest of the technology that surrounded the crypto market people weren’t quite sure about, but it definitely looked like it was here to stay, not unlike the internet and the various dotcom strategies going on in the late ‘90s. Everybody had a good sense of where we were headed at a global level but not really individually what applications were going to work best.”

Bell2Bell’s latest podcast features Hector Bremner, CEO of Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.

Throughout the interview, Bremner discussed Avricore’s business model and the company’s continuing efforts to lead the charge and improve early detection and screening practices throughout the health care industry.

“We’re a company focused on diagnostics. We place a system within the pharmacy where a blood test or a molecular test can be done. A simple sample is collected, and the whole test takes about 15 minutes,” Bremner said. “Our technology is a cloud-based solution that networks these high-quality analyzers from companies like Abbott and is able to then create a testing network in the pharmacy… The patient gets to keep their information, of course… but really, the objective here is to create a global network of pharmacies reporting back real-time information on patient data that can be used for study and research purposes, which is a very, very high demand out there in the sector.”

“My background, funnily enough, was not in health care nor public companies. I was actually in government,” he continued. “Leading into Avricore Health, what got me excited was that we have a disease care system in [Canada], and I’ve always really believed that we need a true health care system that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future. We’re really passionate about leading this charge… We’ve got a company that is in great shape and fully funded. We’re growing, and we’ve got a lot of blue sky ahead of us.”

Bremner then discussed some of the recent milestones for Avricore Health.

Bell2Bell’s latest podcast features Hector Bremner, CEO of Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.

Throughout the interview, Bremner discussed Avricore’s business model and the company’s continuing efforts to lead the charge and improve early detection and screening practices throughout the health care industry.

“We’re a company focused on diagnostics. We place a system within the pharmacy where a blood test or a molecular test can be done. A simple sample is collected, and the whole test takes about 15 minutes,” Bremner said. “Our technology is a cloud-based solution that networks these high-quality analyzers from companies like Abbott and is able to then create a testing network in the pharmacy… The patient gets to keep their information, of course… but really, the objective here is to create a global network of pharmacies reporting back real-time information on patient data that can be used for study and research purposes, which is a very, very high demand out there in the sector.”

“My background, funnily enough, was not in health care nor public companies. I was actually in government,” he continued. “Leading into Avricore Health, what got me excited was that we have a disease care system in [Canada], and I’ve always really believed that we need a true health care system that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future. We’re really passionate about leading this charge… We’ve got a company that is in great shape and fully funded. We’re growing, and we’ve got a lot of blue sky ahead of us.”

Bremner then discussed some of the recent milestones for Avricore Health.

Bell2Bell’s latest podcast features Stephen Jordan, CEO of American Cannabis Partners, a multi-state cannabis company.

Throughout the interview, Jordan discussed the company’s business model and strategic approach to minimizing shareholder risk.

“American Cannabis Partners (“ACP”) is a multi-state operator. We have farms in Northern California, as well as the State of Michigan,” Jordan said. “We have 11 cultivation licenses totaling about 560,000 square foot of canopy space. These are acquired licenses, so it is fully legit. We have a retail license in the State of Michigan, as well. One of the biggest things for us… is assets and safety. That’s one of the hardest things to find in this industry. A lot of people and a lot of companies have products, but they’ve placed themselves in very strenuous liability situations. If they can’t make a product, they no longer have a company. ACP took the opposite direction.”

“We raised capital initially, step-by-step, and we deployed that money into tangible assets – real estate, equipment, things of that nature – just in case some type of bad situation came up or some type of change in a regulatory agency that was no longer a good fit for ACP in that location. We have the ability to liquidate, move and still stay afloat and protect our shareholders,” he continued. “That’s always been a big part for us – assets, assets, assets – and then build the operations out. To this day… we are cash-flow positive, shareholder distribution positive, and we are moving to our third state sometime in the latter half of 2022… preferably on the east coast.”

Jordan then provided some insight into his background in the cannabis sector.

Bell2Bell’s latest podcast features Stephen Jordan, CEO of American Cannabis Partners, a multi-state cannabis company.

Throughout the interview, Jordan discussed the company’s business model and strategic approach to minimizing shareholder risk.

“American Cannabis Partners (“ACP”) is a multi-state operator. We have farms in Northern California, as well as the State of Michigan,” Jordan said. “We have 11 cultivation licenses totaling about 560,000 square foot of canopy space. These are acquired licenses, so it is fully legit. We have a retail license in the State of Michigan, as well. One of the biggest things for us… is assets and safety. That’s one of the hardest things to find in this industry. A lot of people and a lot of companies have products, but they’ve placed themselves in very strenuous liability situations. If they can’t make a product, they no longer have a company. ACP took the opposite direction.”

“We raised capital initially, step-by-step, and we deployed that money into tangible assets – real estate, equipment, things of that nature – just in case some type of bad situation came up or some type of change in a regulatory agency that was no longer a good fit for ACP in that location. We have the ability to liquidate, move and still stay afloat and protect our shareholders,” he continued. “That’s always been a big part for us – assets, assets, assets – and then build the operations out. To this day… we are cash-flow positive, shareholder distribution positive, and we are moving to our third state sometime in the latter half of 2022… preferably on the east coast.”

Jordan then provided some insight into his background in the cannabis sector.